There is only one vaccine trial to start in the month of April
New candidate vaccine for 2019-nCov
Name of Vaccine
NIAID & ModernaTX, Inc
This is a Phase I study
Is a novel lipid nanoparticle (LNP)-encapsulated mRNA-based vaccine that encodes for a full-length, prefusion stabilized spike (S) protein of 2019-novel coronavirus (nCoV).
ClinicalTrials.gov Identifier: NCT04283461